Skip to main content
. 2021 Jul 6;10:e64872. doi: 10.7554/eLife.64872

Figure 7. 7,8-Dihydroxyflavone (7,8-DHF) exerts dual regulation of bone remodeling.

Figure 7.

7,8-DHF promotes osteoblastic proliferation and differentiation through the TrkB-Wnt/β-catenin signaling pathway and inhibits osteoclastogenesis at the same time in vitro. Furthermore, 7,8-DHF improves bone mass, trabecular microarchitecture, tibial biomechanical properties, and bone biochemical indexes in vivo as indicated in an ovariectomy (OVX)-induced osteoporosis rat model.